Barely Significant
← all excerpts

Red blood cell-conjugated biomimetic nanomedicine for enhanced therapy of non-small cell lung cancer.

Theranostics · 2026 · PMC12905782 · PMID 41695485

Europe PMCDOI
1
hedged sentence
0.0500
closest p · 1.0× alpha
0.0500
boldest claim

The sentences

did not reach statistical significancep > 0.05actually significant
However, in the orthotopic lung cancer model, while Osi-RNP-SA-RBC significantly improved antitumor efficacy relative to free Osimertinib (4.2-fold increase), its performance compared to Osi-RNP-RBC (1.1-fold increase) did not reach statistical significance ( p > 0.05).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.